[go: up one dir, main page]

AU2662799A - Modified pharmacologically active agents and improved therapeutic methods employing same - Google Patents

Modified pharmacologically active agents and improved therapeutic methods employing same

Info

Publication number
AU2662799A
AU2662799A AU26627/99A AU2662799A AU2662799A AU 2662799 A AU2662799 A AU 2662799A AU 26627/99 A AU26627/99 A AU 26627/99A AU 2662799 A AU2662799 A AU 2662799A AU 2662799 A AU2662799 A AU 2662799A
Authority
AU
Australia
Prior art keywords
active agents
pharmacologically active
therapeutic methods
methods employing
improved therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26627/99A
Inventor
Ching-San Lai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinox Inc
Original Assignee
Medinox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinox Inc filed Critical Medinox Inc
Publication of AU2662799A publication Critical patent/AU2662799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/36—Esters of dithiocarboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU26627/99A 1998-02-13 1999-02-08 Modified pharmacologically active agents and improved therapeutic methods employing same Abandoned AU2662799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7469498P 1998-02-13 1998-02-13
US60074694 1998-02-13
PCT/US1999/002678 WO1999040787A1 (en) 1998-02-13 1999-02-08 Modified pharmacologically active agents and improved therapeutic methods employing same

Publications (1)

Publication Number Publication Date
AU2662799A true AU2662799A (en) 1999-08-30

Family

ID=22121097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26627/99A Abandoned AU2662799A (en) 1998-02-13 1999-02-08 Modified pharmacologically active agents and improved therapeutic methods employing same

Country Status (2)

Country Link
AU (1) AU2662799A (en)
WO (1) WO1999040787A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
KR20040026680A (en) * 2001-07-09 2004-03-31 콤비네이토릭스, 인코포레이티드 Combinations for the treatment of inflammatory disorders
AU2003226603A1 (en) 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
MXPA06013345A (en) 2004-05-18 2008-10-31 Acorda Therapeutics Inc Methods of purifying chondroitinase and stable formulations thereof.
JP4992091B2 (en) * 2005-02-17 2012-08-08 ハダシット メディカル リサーチ サービシーズ アンド デベロップメント リミテッド Bisphosphonates for treating endometriosis
US7485295B2 (en) 2005-09-26 2009-02-03 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase ABCI mutants
CA2666536C (en) 2006-10-10 2018-08-07 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug

Also Published As

Publication number Publication date
WO1999040787A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
AU2466099A (en) Pharmaceutically active compounds and methods of use thereof
IL137346A0 (en) Pharmaceutically active morpholinol
AU2111199A (en) Benzenesulfonamides and benzamides as therapeutic agents
IL127559A0 (en) Compounds and methods for providing pharmacologically active preparations and uses thereof
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
AU715620C (en) Therapeutic methods and uses
EP1115396A4 (en) Pharmaceutically active compounds and methods of use thereof
AU1969800A (en) Combination of active agents
AU5965399A (en) Pharmaceutically active composition
AU2451500A (en) Therapeutic agents
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
AU5973600A (en) Therapeutic agents
AU5531798A (en) Pharmacologically active compounds and use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU1171099A (en) Therapeutic agents
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU2001262699A1 (en) Biologically active agents and drugs
AU6150200A (en) Therapeutic agents
AU5005099A (en) Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
AU5817400A (en) Therapeutic agents
EP1041986A4 (en) Pharmaceutically active compound and methods of use
AU6302300A (en) Therapeutic agents
AU5817500A (en) Therapeutic agents
AU2002315922A1 (en) Pharmaceutically active morpholinol

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase